600763 通策医疗
2025/03 - 三个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入744,6125.11%2,873,7772,846,5082,718,6122,780,725
减:营业总成本516,7864.89%2,228,5652,200,0292,029,1511,873,083
    其中:营业成本415,4485.91%1,767,3061,749,7541,609,0251,500,000
               财务费用9,286-13.18%48,36049,58946,55323,020
               资产减值损失----155------
公允价值变动收益----1,417------
投资收益11,195-9.20%46,42760,19338,30156,134
    其中:对联营企业和合营企业的投资收益7,111-7.75%32,63634,80010,74812,396
营业利润240,0705.18%698,632711,888733,906974,891
利润总额239,8955.15%694,009708,824737,984974,584
减:所得税费用23,792-1.98%121,878130,434122,306188,434
净利润216,1036.00%572,131578,390615,678786,150
减:非控股权益32,1784.77%70,70577,94967,40983,343
股东净利润183,9256.22%501,427500,441548,269702,807

市场价值指针
每股收益 (元) *0.4105.13%1.1201.1201.7102.190
每股派息 (元) *----0.4500.436----
每股净资产 (元) *9.411-24.11%9.00511.86710.3258.984
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容